Mohammad H Alshaer (Mohammad Alshaer, M H Al-Shaer, Mohammad H Al-Shaer)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 29

Top Venues

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

Pharmacotherapy

The Journal of antimicrobial chemotherapy

University of Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Florida Aug 15 2016 - May 15 2020

United States

PHD :: Pharmacotherapy and Translational Research

Jordan University of Science and Technology Aug 01 2004 - Jun 21 2010

Jordan

PHD

Publications

Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy 43 (8) (2023)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy 43 (8) (2023)
Jack Chang, Jiajun Liu, Mohammad H Alshaer, Veena Venugopalan, Nicole Maranchick, Charles A Peloquin, Nathaniel James Rhodes, Marc H Scheetz
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults. The Journal of antimicrobial chemotherapy (2023)
Nicole F Maranchick, Jessica Webber, Mohammad H Alshaer, Timothy W Felton, Charles A Peloquin
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Nicole F Maranchick, Jessica Webber, Mohammad H Alshaer, Timothy W Felton, Charles A Peloquin
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Daniel S Graciaa, Maia Kipiani, Matthew J Magee, Lali Mikiashvili, Ketevan Barbakadze, Nino Bablishvili, Sara C Auld, Wael A Alghamdi, Mohammad H Alshaer, Charles A Peloquin, Zaza Avaliani, Henry M Blumberg, Russell R Kempker
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 66 (9) (2022)
Veena Venugopalan, Danielle Casaus, Leonie Kainz, Cara N Slaton, Natalie Hurst, Maria Bruzzone, Calvin Hu, Gabriel Sword, Kartikeya Cherabuddi, Nicole Iovine, Jiajun Liu, Marc H Scheetz, Nathaniel Rhodes, Nicole Maranchick, Charles A Peloquin, Kenneth Klinker, Mohammad H Alshaer
Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity. Pharmacotherapy (2022)
Ashlan J Kunz Coyne, Mohammad H Alshaer, Anthony M Casapao, Veena Venugopalan, Carmen Isache, Jason A Ferreira, Christopher A Jankowski
Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection. Antimicrobial agents and chemotherapy 66 (10) (2022)
Mohammad H Alshaer, Brooke Barlow, Nicole Maranchick, Miriam Moser, Leon Gramss, Heinz Burgmann, Valentin Al Jalali, Michael Wölfl-Duchek, Walter Jäger, Stefan Poschner, Walter Plöchl, Andrea Reinprecht, Karl Rössler, Andreas Gruber, Markus Zeitlinger, Charles A Peloquin, Arthur Hosmann
Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue. Antimicrobial agents and chemotherapy 66 (8) (2022)
Mohammad H Alshaer, Charles A Peloquin
Another trial for the TARGET trial. Intensive care medicine 48 (6) (2022)
Mohammad H Alshaer, Nicole Maranchick, Chen Bai, Kelly L Maguigan, Bethany R Shoulders, Timothy W Felton, Sumith K Mathew, Mamoun T Mardini, Charles A Peloquin
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia. Antimicrobial agents and chemotherapy 66 (7) (2022)
Prakruti S Rao, Christopher C Moore, Amir A Mbonde, Edwin Nuwagira, Patrick Orikiriza, Dan Nyehangane, Mohammad H Alshaer, Charles A Peloquin, Jean Gratz, Suporn Pholwat, Rinah Arinaitwe, Yap Boum, Juliet Mwanga-Amumpaire, Eric R Houpt, Leonid Kagan, Scott K Heysell, Conrad Muzoora
Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Mohammad H Alshaer, Kelly Maguigan, Jennifer Ashton, Veena Venugopalan, Molly E Droege, Carolyn Dosen Philpott, Christopher A Droege, Daniel P Healy, Eric W Mueller, Charles A Peloquin
Applying cefepime population pharmacokinetics on critically ill patients receiving continuous renal replacement therapy. Antimicrobial agents and chemotherapy (2021)
Mohammad H Alshaer, Sylvain Goutelle, Barbara A Santevecchi, Bethany R Shoulders, Veena Venugopalan, Kartikeya Cherabuddi, Jiajun Liu, Patrick J Kiel, Jason Alexander Roberts, Fekade Bruck Sime, Marc H Scheetz, Michael N Neely, Charles A Peloquin
Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics. Antimicrobial agents and chemotherapy 66 (2) (2021)
Abdullah Alsultan, Mohammad H Alshaer, Wael A Alghamdi, Charles A Peloquin
Comment on: The case for 'conservative pharmacotherapy'. The Journal of antimicrobial chemotherapy 76 (7) (2021)
Mohammad H Alshaer, Carolyn Dosen Philpott, Christopher A Droege, Joshua D Courter, Daniel P Healy, Molly E Droege, Neil E Ernst, Eric W Mueller, Charles A Peloquin
Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 65 (6) (2021)
Kelly L Maguigan, Mohammad H Alshaer, Charles A Peloquin
Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach. Antibiotics (Basel, Switzerland) 10 (10) (2021)
Mohammad H Alshaer, Anne-Grete Märtson, Wael A Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Eric R Houpt, David Ashkin, David E Griffith, J Peter Cegielski, Scott K Heysell, Charles A Peloquin
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 64 (9) (2020)
Mohammad H Alshaer, Michael N Neely, Jiajun Liu, Kartikeya Cherabuddi, Veena Venugopalan, Nathaniel James Rhodes, Kenneth P Klinker, Marc H Scheetz, Charles A Peloquin
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing. Antimicrobial agents and chemotherapy 64 (9) (2020)
Wael A Alghamdi, Mohammad H Alshaer, Kenneth P Klinker, Charles A Peloquin
Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series. Clinical case reports 8 (7) (2020)
Wael A Alghamdi, Mohammad H Alshaer, Guohua An, Abdullah Alsultan, Maia Kipiani, Ketevan Barbakadze, Lali Mikiashvili, David Ashkin, David E Griffith, J Peter Cegielski, Russell R Kempker, Charles A Peloquin
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis. Antimicrobial agents and chemotherapy 64 (10) (2020)
Wael A Alghamdi, Abdullah Alsultan, Mohammad H Alshaer, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, Stephan Schmidt, Scott K Heysell, Russell R Kempker, J Peter Cegielski, Charles A Peloquin
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis. Antimicrobial agents and chemotherapy 63 (5) (2019)
Mohammad H Alshaer, Wael A Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, J Peter Cegielski, Russell R Kempker, Scott K Heysell, Charles A Peloquin
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. Antimicrobial agents and chemotherapy 63 (7) (2019)
Russell R Kempker, Wael A Alghamdi, Mohammad H Alshaer, Gena Burch, Charles A Peloquin
A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment. Antimicrobial agents and chemotherapy (2019)
Galina Lyles, Oleg Ogarkov, Svetlana Zhdanova, Charles A Peloquin, Andrew Ebers, Herman Pfaeffle, Mohammad H Alshaer, Elena Moiseeva, Elena Zorkaltseva, Mikhail Koscheev, Eric R Houpt, Scott K Heysell
Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity. The European respiratory journal 51 (5) (2018)
Wael A Alghamdi, Mohammad H Alshaer, Charles A Peloquin
Protein Binding of First-Line Antituberculosis Drugs. Antimicrobial agents and chemotherapy 62 (7) (2018)
Mohammad H Alshaer, Hazem Elewa, Yosra Alkabab, Lama H Nazer, Scott K Heysell
Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar. BMC infectious diseases 18 (1) (2018)
Christoph Lange, Wael A Alghamdi, Mohammad H Alshaer, Susanna Brighenti, A H Diacon, A R DiNardo, H P Grobbel, M I Gröschel, F von Groote-Bidlingmaier, M Hauptmann, J Heyckendorf, N Köhler, T A Kohl, M Merker, S Niemann, C A Peloquin, M Reimann, U E Schaible, D Schaub, V Schleusener, T Thye, T Schön
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of internal medicine (2018)
Omamah Alfarisi, Wael A Alghamdi, Mohammad H Alshaer, Kelly E Dooley, Charles A Peloquin
Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis? Expert review of clinical pharmacology 10 (10) (2017)

Mohammad H Alshaer.css-eqlu8i{font-size:small;padding-left:4px;} (Mohammad Alshaer, M H Al-Shaer, Mohammad H Al-Shaer)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad H Alshaer (Mohammad Alshaer, M H Al-Shaer, Mohammad H Al-Shaer)